Domov › Steatotična bolezen jeter › New York
Klinične študije za Steatotična bolezen jeter v New York
17 študij za Steatotična bolezen jeter išče udeležence na lokacijah v New York.
Mesta v New York
Uradno besedilo študije (angleško)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Albany
- 89bio Clinical Study Site, New York
- 89bio Clinical Study Site, New York
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Albany
- 89bio Clinical Study Site, Carmel
- 89bio Clinical Study Site, New York
Vključevanje udeležencevFaza 3
Starost 18–80 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06318169A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, New York
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07704892Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- New York Presbyterian/Weill Cornell, New York
- Columbia University Iriving School of Medicine, New York
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05832229A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Columbia University Irving Medical Center, New York
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Research Foundation of SUNY - University of Buffalo, Buffalo
- NYU Langone Health, New York
- IMA Clinical Research Manhattan, New York
- in še 2
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Buffalo
- Akero Clinical Study Site, Manhasset
- Akero Clinical Study Site, New York
- in še 3
Vključevanje udeležencevFaza 3
Starost 18–80 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, East Syracuse
- GSK Investigational Site, New York
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07221188Human Models of Selective Insulin Resistance: Alpelisib, Part I
- Columbia University Irving Medical Center, New York
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–70 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT06354088A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, New York
Vključevanje udeležencevFaza 2
Starost 18–70 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, East Syracuse
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, New York
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 8. jul. 2026 · NCT06920043Effect of Insulin Lowering on Lipogenesis
- Columbia University Irving Medical Center, New York
Vključevanje udeležencevFaza 1
Starost 18–65 · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT07403604Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- Icahn School of Medicine at Mount Sinai, New York
Vključevanje udeležencev
Starost 18–75 · Vsi spoli · Posodobljeno 19. maj 2026 · NCT04054310Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
- Weill Cornell Medicine, New York
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 27. feb. 2026 · NCT05332613High Fructose Diet, the Gut Microbiome, and Metabolic Health
- Mount Sinai Morningside, New York
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 25–45 · Vsi spoli · Posodobljeno 17. dec. 2025 · NCT06329544Blood Collection Biorepository for Liver Disease Research
- University at Buffalo, Buffalo General Medical Center, Buffalo
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 7 in več · Vsi spoli · Posodobljeno 27. avg. 2025 · NCT03025074Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.